Talphera (TLPH) Change in Inventory (2016 - 2023)
Talphera's (TLPH) quarterly Change in Inventory came in at -$61000.0 in Q1 2023, down 7.02% year-on-year from -$65603.8 in Q1 2022, and down 119.24% quarter-over-quarter from $317000.0 in Q4 2022.
Talphera (TLPH) Change in Inventory (2016 - 2023) Analysis & Trends
Talphera's Change in Inventory history runs 8 years deep, the most recent figure standing at -$61000.0 for Q1 2023.
- On a quarterly basis, Change in Inventory fell 7.02% year-over-year to -$61000.0 in Q1 2023; TTM through Dec 2023 was -$61000.0, a 157.01% decrease from a year earlier, with the FY2023 full-year figure at -$61000.0, down 157.01% from the prior year.
- Change in Inventory retreated to -$61000.0 in Q1 2023 per TLPH's latest filing, from $317000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $1.5 million in Q1 2019 and bottomed at -$457000.0 in Q3 2020.
- The 5-year median for Change in Inventory is -$38000.0 (2021), against an average of $163294.1.
- Across the five-year window, Change in Inventory jumped 20650.0% in 2019 and tumbled 278.95% in 2022, its largest moves.
- Year by year, Change in Inventory stood at $411000.0 in 2019, then plunged by 154.26% to -$223000.0 in 2020, then soared by 151.57% to $115000.0 in 2021, then surged by 175.65% to $317000.0 in 2022, then plunged by 119.24% to -$61000.0 in 2023.
- Per Business Quant, the three latest TLPH Change in Inventory figures stand at -$61000.0 (Q1 2023), $317000.0 (Q4 2022), and -$9000.0 (Q3 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -61,000.00 |
| Mar 31, 2023 | -61,000.00 |
| Dec 31, 2022 | 317,000.00 |
| Dec 31, 2022 | 317,000.00 |
| Sep 30, 2022 | -9,000.00 |
| Sep 30, 2022 | -9,000.00 |
| Jun 30, 2022 | -144,000.00 |
| Jun 30, 2022 | -144,000.00 |
| Mar 31, 2022 | -57,000.00 |
| Mar 31, 2022 | -57,000.00 |
| Dec 31, 2021 | 115,000.00 |
| Dec 31, 2021 | 115,000.00 |
| Sep 30, 2021 | 323,000.00 |
| Sep 30, 2021 | 323,000.00 |
| Jun 30, 2021 | -38,000.00 |
| Jun 30, 2021 | -38,000.00 |
| Mar 31, 2021 | -105,000.00 |
| Mar 31, 2021 | -105,000.00 |
| Dec 31, 2020 | -223,000.00 |
| Dec 31, 2020 | -223,000.00 |